Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription Articles published in Clin Breast Cancer Retrieve available abstracts of 250 articles: HTML format Text format

Single Articles

May 2018
1. LECLERC AF, Slomian J, Jerusalem G, Coucke P, et al
   Exercise and Education Program After Breast Cancer: Benefits on Quality of Life and Symptoms at 3, 6, 12, and 24 Months' Follow-up.
   Clin Breast Cancer. 2018 May 19. pii: S1526-8209(17)30809.
   PubMed     Text format     Abstract available
   
   
   
2. CO M, Ng J, Kwong A
   Air Travel Safety in Postoperative Breast Cancer Patients: A Systematic Review.
   Clin Breast Cancer. 2018 May 17. pii: S1526-8209(18)30236.
   PubMed     Text format     Abstract available
   
   
   
3. KOZAK MM, Jacobson CE, von Eyben R, Walck E, et al
   Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy.
   Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30796.
   PubMed     Text format     Abstract available
   
   
   
4. MCINTIRE PJ, Irshaid L, Liu Y, Chen Z, et al
   Hot Spot and Whole-Tumor Enumeration of CD8(+) Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast Cancer.
   Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30839.
   PubMed     Text format     Abstract available
   
   
   
5. DENG Y, Ma G, Li W, Wang T, et al
   CDK4/6 Inhibitors in Combination With Hormone Therapy for HR(+)/HER2(-) Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
   Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30798.
   PubMed     Text format     Abstract available
   
   
   
6. JABIR RS, Ho GF, Annuar MABA, Stanslas J, et al
   Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
   Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30628.
   PubMed     Text format     Abstract available
   
   
   April 2018
7. LADWA R, Kalas T, Pathmanathan S, Woodward N, et al
   Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer.
   Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30105.
   PubMed     Text format     Abstract available
   
   
   
8. DHAKAL A, Matthews CM, Levine EG, Salerno KE, et al
   Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment.
   Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30805.
   PubMed     Text format     Abstract available
   
   
   
9. KOPS NL, Bessel M, Caleffi M, Ribeiro RA, et al
   Body Weight and Breast Cancer: Nested Case-Control Study in Southern Brazil.
   Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30073.
   PubMed     Text format     Abstract available
   
   
   
10. RAYSON D, Payne JI, Michael JCR, Tsuruda KM, et al
    Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30829.
    PubMed     Text format     Abstract available
    
    
    
11. CHO WK, Choi DH, Park W, Cha H, et al
    Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(17)30765.
    PubMed     Text format     Abstract available
    
    
    
12. QINGQING H, Jian Z, Dayong Z, Ziyi F, et al
    Robot-Assisted Internal Mammary Lymph Node Chain Dissection for Breast Cancer.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30134.
    PubMed     Text format    
    
    
    
13. KIM HJ, Lee MH, Lee JE, Park S, et al
    Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30019.
    PubMed     Text format     Abstract available
    
    
    
14. HU ZY, Xiao H, Xiao M, Tang Y, et al
    Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30048.
    PubMed     Text format     Abstract available
    
    
    
15. KENDZIERSKI DC, Schneider BP, Kiel PJ
    Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review.
    Clin Breast Cancer. 2018 Apr 18. pii: S1526-8209(17)30722.
    PubMed     Text format     Abstract available
    
    
    
16. CADOO KA, Kaufman PA, Seidman AD, Chang C, et al
    Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Apr 7. pii: S1526-8209(17)30768.
    PubMed     Text format     Abstract available
    
    
    
17. NG T, Phey XY, Yeo HL, Shwe M, et al
    Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Clin Breast Cancer. 2018 Apr 6. pii: S1526-8209(17)30767.
    PubMed     Text format     Abstract available
    
    
    
18. MUTSCHLER NS, Scholz C, Friedl TWP, Zwingers T, et al
    Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
    Clin Breast Cancer. 2018;18:175-183.
    PubMed     Text format     Abstract available
    
    
    March 2018
19. CORTES J, Perez-Garcia J, Whiting S, Wan Y, et al
    Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.
    Clin Breast Cancer. 2018 Mar 30. pii: S1526-8209(17)30778.
    PubMed     Text format     Abstract available
    
    
    
20. KIM S, Moon BI, Lim W, Park S, et al
    Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers.
    Clin Breast Cancer. 2018 Mar 23. pii: S1526-8209(17)30736.
    PubMed     Text format     Abstract available
    
    
    
21. TAHERIPANAH R, Balash F, Anbiaee R, Mahmoodi M, et al
    Breast Cancer and Ovulation Induction Treatments.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30455.
    PubMed     Text format     Abstract available
    
    
    
22. MORRIS PG, Rota S, Cadoo K, Zamora S, et al
    Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30810.
    PubMed     Text format     Abstract available
    
    
    
23. UM E, Kang JW, Lee S, Kim HJ, et al
    Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30614.
    PubMed     Text format     Abstract available
    
    
    
24. MATTHIESSEN LW, Keshtgar M, Curatolo P, Kunte C, et al
    Electrochemotherapy for Breast Cancer-Results From the INSPECT Database.
    Clin Breast Cancer. 2018 Mar 14. pii: S1526-8209(17)30397.
    PubMed     Text format     Abstract available
    
    
    
25. REINERT T, Nogueira-Rodrigues A, Kestelman FP, Ashton-Prolla P, et al
    The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Mar 12. pii: S1526-8209(18)30026.
    PubMed     Text format     Abstract available
    
    
    
26. MIYAGAWA Y, Araki K, Bun A, Ozawa H, et al
    Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30724.
    PubMed     Text format     Abstract available
    
    
    
27. COSPHIADI I, Atmakusumah TD, Siregar NC, Muthalib A, et al
    Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30777.
    PubMed     Text format     Abstract available
    
    
    
28. YARDLEY DA, Hart LL, Ward PJ, Wright GL, et al
    Cabazitaxel Plus Lapatinib as Therapy for HER2(+) Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30668.
    PubMed     Text format     Abstract available
    
    
    
29. MEATTINI I, Pezzulla D, Saieva C, Bernini M, et al
    Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study.
    Clin Breast Cancer. 2018 Mar 2. pii: S1526-8209(18)30015.
    PubMed     Text format     Abstract available
    
    
    February 2018
30. BINKLEY JM, Stratford P, Kirkpatrick S, Farley CR, et al
    Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery.
    Clin Breast Cancer. 2018 Feb 21. pii: S1526-8209(18)30054.
    PubMed     Text format     Abstract available
    
    
    
31. DEFAZIO MV, Dervishaj OA, Bozzuto LM, Pittman TA, et al
    Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature.
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30842.
    PubMed     Text format    
    
    
    
32. HERSKOVIC AC, Wu X, Christos PJ, Nagar H, et al
    Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30782.
    PubMed     Text format     Abstract available
    
    
    
33. RAO N, Chen K, Yang Q, Niu J, et al
    Proof-of-Concept Study of 3-D-Printed Mold-Guided Breast-Conserving Surgery in Breast Cancer Patients.
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(18)30039.
    PubMed     Text format     Abstract available
    
    
    
34. YAMASHITA N, Tokunaga E, Iimori M, Inoue Y, et al
    Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
    Clin Breast Cancer. 2018 Feb 16. pii: S1526-8209(17)30629.
    PubMed     Text format     Abstract available
    
    
    
35. ZAHEDI H, Djalalinia S, Sadeghi O, Asayesh H, et al
    Dietary Inflammatory Potential Score and Risk of Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Feb 7. pii: S1526-8209(17)30725.
    PubMed     Text format     Abstract available
    
    
    
36. PALAZZO A, Dellapasqua S, Munzone E, Bagnardi V, et al
    Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30737.
    PubMed     Text format     Abstract available
    
    
    
37. CUI Q, Kong D, Li Z, Ahiable P, et al
    Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30662.
    PubMed     Text format     Abstract available
    
    
    
38. BLACKWELL K, Gligorov J, Jacobs I, Twelves C, et al
    The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30406.
    PubMed     Text format     Abstract available
    
    
    January 2018
39. HASHEMI M, Sanaei S, Hashemi SM, Eskandari E, et al
    Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30804.
    PubMed     Text format     Abstract available
    
    
    
40. ERSOY YE, Kadioglu H
    Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30830.
    PubMed     Text format     Abstract available
    
    
    
41. JABIR FA, Hoidy WH
    Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30534.
    PubMed     Text format     Abstract available
    
    
    
42. FARD ZT, Nafisi N
    The Relationship Between 6 Polymorphisms of Caveolin-1 Gene and the Risk of Breast Cancer.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(16)30439.
    PubMed     Text format     Abstract available
    
    
    
43. KOJIMA Y, Kawamoto H, Nishikawa T, Hayami R, et al
    Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m(2)) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Jan 11. pii: S1526-8209(17)30615.
    PubMed     Text format     Abstract available
    
    
    
44. GU J, Groot G, Boden C, Busch A, et al
    Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2018 Jan 3. pii: S1526-8209(17)30691.
    PubMed     Text format     Abstract available
    
    
    December 2017
45. YADAV S, Ladkany R, Yadav D, Alhalabi O, et al
    Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Dec 30. pii: S1526-8209(17)30334.
    PubMed     Text format     Abstract available
    
    
    
46. WU JD, Hong CQ, Huang WH, Wei XL, et al
    L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
    Clin Breast Cancer. 2017 Dec 28. pii: S1526-8209(17)30523.
    PubMed     Text format     Abstract available
    
    
    
47. BHAVE MA, Speth KA, Kidwell KM, Lyden A, et al
    Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Clin Breast Cancer. 2017 Dec 27. pii: S1526-8209(17)30624.
    PubMed     Text format     Abstract available
    
    
    
48. MORIKAWA A, Wang R, Patil S, Diab A, et al
    Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30394.
    PubMed     Text format     Abstract available
    
    
    
49. GORNSTEIN EL, Sandefur S, Chung JH, Gay LM, et al
    BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30680.
    PubMed     Text format    
    
    
    
50. YERUVA SLH, Javadi MS, Stearns V
    Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30533.
    PubMed     Text format    
    
    
    
51. MEISEL J, Zhang C, Neely C, Mendoza P, et al
    Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.
    Clin Breast Cancer. 2017 Dec 14. pii: S1526-8209(17)30562.
    PubMed     Text format     Abstract available
    
    
    
52. MOLDERINGS GJ, Knuchel-Clarke R, Hertfelder HJ, Kuhl C, et al
    Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30532.
    PubMed     Text format    
    
    
    
53. KUBA S, Maeda S, Matsumoto M, Yamanouchi K, et al
    Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30626.
    PubMed     Text format     Abstract available
    
    
    
54. SHEPPARD VB, de Mendoza AH, He J, Jennings Y, et al
    Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30356.
    PubMed     Text format     Abstract available
    
    
    
55. CHIBA A, Raman R, Thomas A, Lamy PJ, et al
    Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Clin Breast Cancer. 2017 Dec 11. pii: S1526-8209(17)30324.
    PubMed     Text format     Abstract available
    
    
    
56. ELGHOROURY EA, ElDine HG, Kamel SA, Abdelrahman AH, et al
    Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 7. pii: S1526-8209(17)30458.
    PubMed     Text format     Abstract available
    
    
    
57. SCIMECA M, Antonacci C, Toschi N, Giannini E, et al
    Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.
    Clin Breast Cancer. 2017 Dec 5. pii: S1526-8209(17)30209.
    PubMed     Text format     Abstract available
    
    
    November 2017
58. BASTIAANNET E, Charman J, Johannesen TB, Schrodi S, et al
    A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Nov 29. pii: S1526-8209(17)30728.
    PubMed     Text format     Abstract available
    
    
    
59. LANDMAN Y, Ilouze M, Wein S, Neiman V, et al
    Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30561.
    PubMed     Text format    
    
    
    
60. HAMELINCK VC, Bastiaannet E, Pieterse AH, van de Velde CJH, et al
    Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30409.
    PubMed     Text format     Abstract available
    
    
    
61. RASOOL I, Afroze D, Wani KA, Yousuf A, et al
    Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30631.
    PubMed     Text format     Abstract available
    
    
    
62. FURRER D, Jacob S, Michaud A, Provencher L, et al
    Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30318.
    PubMed     Text format     Abstract available
    
    
    
63. FLEMING CA, McCarthy K, Ryan C, McCarthy A, et al
    Evaluation of Discordance in Primary Tumor and Lymph Node Response After Neoadjuvant Therapy in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30679.
    PubMed     Text format     Abstract available
    
    
    
64. CHANG HT, Pan HJ, Lee CH
    Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30357.
    PubMed     Text format     Abstract available
    
    
    
65. KIM JY, Jung EJ, Park HJ, Lee JH, et al
    Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30504.
    PubMed     Text format     Abstract available
    
    
    
66. INOUE Y, Yamashita N, Kitao H, Tanaka K, et al
    Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30385.
    PubMed     Text format     Abstract available
    
    
    
67. GRANDI G, Toss A, Cagnacci A, Marcheselli L, et al
    Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
    Clin Breast Cancer. 2017 Nov 14. pii: S1526-8209(17)30488.
    PubMed     Text format     Abstract available
    
    
    
68. CHKHEIDZE R, Sanders MAG, Haley B, Leitch AM, et al
    Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
    Clin Breast Cancer. 2017 Nov 10. pii: S1526-8209(17)30456.
    PubMed     Text format     Abstract available
    
    
    
69. KARAKAS Y, Dizdar O, Aksoy S, Hayran M, et al
    The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30449.
    PubMed     Text format     Abstract available
    
    
    
70. HOU Y, Nitta H, Wei L, Banks PM, et al
    Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30604.
    PubMed     Text format     Abstract available
    
    
    
71. RAGHAVENDRA A, Sinha AK, Valle J, Shen Y, et al
    Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30621.
    PubMed     Text format     Abstract available
    
    
    
72. FIGUEIREDO FWDS, Adami F
    Income Inequality and Mortality Owing to Breast Cancer: Evidence From Brazil.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30526.
    PubMed     Text format     Abstract available
    
    
    
73. WADASADAWALA T, Lewis S, Parmar V, Budrukkar A, et al
    Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30383.
    PubMed     Text format     Abstract available
    
    
    
74. FISCHER A, Ziogas A, Anton-Culver H
    Negative Valence Life Events Promote Breast Cancer Development.
    Clin Breast Cancer. 2017 Nov 1. pii: S1526-8209(16)30501.
    PubMed     Text format     Abstract available
    
    
    October 2017
75. MCREE AJ, Marcom PK, Moore DT, Zamboni WC, et al
    A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30313.
    PubMed     Text format     Abstract available
    
    
    
76. MCVEIGH TP, Wiggins J, Ward S, Kemp Z, et al
    Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30489.
    PubMed     Text format     Abstract available
    
    
    
77. PROCHOWSKI IAMURRI A, Ponziani M, Macchini M, Fogante M, et al
    Evaluation of Multifocality and Multicentricity With Breast Magnetic Resonance Imaging in Each Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30164.
    PubMed     Text format     Abstract available
    
    
    
78. SALOUSTROS E, Nikolaou M, Kalbakis K, Polyzos A, et al
    Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group.
    Clin Breast Cancer. 2017 Oct 24. pii: S1526-8209(17)30153.
    PubMed     Text format     Abstract available
    
    
    
79. HARDEFELDT PJ, Penninkilampi R, Edirimanne S, Eslick GD, et al
    Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies.
    Clin Breast Cancer. 2017 Oct 17. pii: S1526-8209(16)30429.
    PubMed     Text format     Abstract available
    
    
    
80. KUROSKY SK, Mitra D, Zanotti G, Kaye JA, et al
    Treatment Patterns and Outcomes of Patients With Metastatic ER(+)/HER-2(-) Breast Cancer: A Multicountry Retrospective Medical Record Review.
    Clin Breast Cancer. 2017 Oct 14. pii: S1526-8209(17)30060.
    PubMed     Text format     Abstract available
    
    
    
81. CHANG AE, Wu QV, Jenkins IC, Specht JM, et al
    Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 9. pii: S1526-8209(17)30280.
    PubMed     Text format     Abstract available
    
    
    
82. JANDIAL R, Hoshide R, Waters JD, Somlo G, et al
    Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30417.
    PubMed     Text format     Abstract available
    
    
    
83. HIEKEN TJ, Murphy BL, Boughey JC, Degnim AC, et al
    Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30370.
    PubMed     Text format     Abstract available
    
    
    
84. RAISS H, Peron J, Tartas S, Trillet-Lenoir V, et al
    Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30072.
    PubMed     Text format    
    
    
    
85. HAYASHI N, Takahashi Y, Matsuda N, Tsunoda H, et al
    The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 3. pii: S1526-8209(17)30319.
    PubMed     Text format     Abstract available
    
    
    September 2017
86. HOUSSAMI N
    Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
    Clin Breast Cancer. 2017 Sep 28. pii: S1526-8209(17)30558.
    PubMed     Text format     Abstract available
    
    
    
87. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
    Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Clin Breast Cancer. 2017 Sep 27. pii: S1526-8209(17)30512.
    PubMed     Text format     Abstract available
    
    
    
88. ITO T, Oura S, Nagamine S, Takahashi M, et al
    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241.
    PubMed     Text format     Abstract available
    
    
    
89. LEAL AD, Van Houten H, Sangaralingham L, Freedman RA, et al
    Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.
    Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422.
    PubMed     Text format     Abstract available
    
    
    
90. AKIMOTO E, Kadoya T, Kajitani K, Emi A, et al
    Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30037.
    PubMed     Text format     Abstract available
    
    
    
91. WU J, Wang S, Liu F, Li S, et al
    Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30157.
    PubMed     Text format     Abstract available
    
    
    
92. DIANATINASAB M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, et al
    Socioeconomic Factors, Health Behavior, and Late-Stage Diagnosis of Breast Cancer: Considering the Impact of Delay in Diagnosis.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30358.
    PubMed     Text format     Abstract available
    
    
    
93. MANN JM, Wu X, Christos P, Nagar H, et al
    The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30461.
    PubMed     Text format     Abstract available
    
    
    
94. SAFRA T, Kaufman B, Kadouri L, Efrat Ben-Baruch N, et al
    Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30180.
    PubMed     Text format     Abstract available
    
    
    
95. SPINELLI VARELLA MA, Teixeira da Cruz J, Rauber A, Varella IS, et al
    Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(16)30505.
    PubMed     Text format     Abstract available
    
    
    
96. OBERGUGGENBERGER A, Meraner V, Sztankay M, Hilbert A, et al
    Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors.
    Clin Breast Cancer. 2017 Sep 18. pii: S1526-8209(17)30454.
    PubMed     Text format     Abstract available
    
    
    
97. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Pernas S, et al
    The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
    Clin Breast Cancer. 2017 Sep 4. pii: S1526-8209(17)30565.
    PubMed     Text format     Abstract available
    
    
    
98. ANAMPA J, Chen A, Wright J, Patel M, et al
    Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(17)30468.
    PubMed     Text format     Abstract available
    
    
    
99. ROGOZ B, Houze de l'Aulnoit A, Duhamel A, Houze de l'Aulnoit D, et al
    Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(16)30427.
    PubMed     Text format     Abstract available
    
    
    August 2017
100. CHAMP CE, Ohri N, Klement RJ, Cantor M, et al
     Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.
     Clin Breast Cancer. 2017 Aug 24. pii: S1526-8209(17)30285.
     PubMed     Text format     Abstract available
     
     
     
101. CHAO YL, Anders CK
     TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
     Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30369.
     PubMed     Text format    
     
     
     
102. WANG Y, Brodsky AS, Xiong J, Lopresti ML, et al
     Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
     Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30349.
     PubMed     Text format     Abstract available
     
     
     
103. CID S, Eiro N, Fernandez B, Sanchez R, et al
     Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
     Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30189.
     PubMed     Text format     Abstract available
     
     
     
104. CHOI WJ, Kim WK, Shin HJ, Cha JH, et al
     Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
     Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30058.
     PubMed     Text format     Abstract available
     
     
     
105. AZIM HA, Abdel-Malek R, Kassem L
     Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
     Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30235.
     PubMed     Text format     Abstract available
     
     
     
106. KOOL M, Bastiaannet E, Van de Velde CJH, Marang-van de Mheen PJ, et al
     Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
     Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30212.
     PubMed     Text format     Abstract available
     
     
     
107. DONG H, Huang Y, Song F, Dai H, et al
     Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
     Clin Breast Cancer. 2017 Aug 15. pii: S1526-8209(17)30321.
     PubMed     Text format     Abstract available
     
     
     
108. CHEN W, Huang Y, Lewis GD, Szeja SS, et al
     Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
     Clin Breast Cancer. 2017 Aug 10. pii: S1526-8209(17)30185.
     PubMed     Text format     Abstract available
     
     
     
109. MOUNSEY LA, Deal AM, Keith KC, Benbow JM, et al
     Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
     Clin Breast Cancer. 2017 Aug 9. pii: S1526-8209(17)30036.
     PubMed     Text format     Abstract available
     
     
     
110. ZHOU J, Guo FJ, Hao XP, Chen CJ, et al
     Use of Breast Magnetic Resonance Imaging and Ultrasonography for Identifying Nonpalpable Axillae Metastases in Newly Diagnosed Breast Cancer Patients.
     Clin Breast Cancer. 2017 Aug 9. pii: S1526-8209(17)30348.
     PubMed     Text format     Abstract available
     
     
     July 2017
111. LI L, Pan Z
     Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials.
     Clin Breast Cancer. 2017 Jul 25. pii: S1526-8209(16)30358.
     PubMed     Text format     Abstract available
     
     
     
112. NAMURA M, Tsunoda H, Yagata H, Hayashi N, et al
     Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
     Clin Breast Cancer. 2017 Jul 21. pii: S1526-8209(17)30107.
     PubMed     Text format     Abstract available
     
     
     
113. ALTUNDAG K
     Do We Consider Locoregional Treatment of Primary Site in Patients With De Novo Stage IV Breast Cancer?: Numerous Data Are Accumulating!
     Clin Breast Cancer. 2017 Jul 20. pii: S1526-8209(17)30443.
     PubMed     Text format    
     
     
     
114. THAKUR KK, Bordoloi D, Kunnumakkara AB
     Alarming Burden of Triple-negative Breast Cancer in India.
     Clin Breast Cancer. 2017 Jul 20. pii: S1526-8209(17)30160.
     PubMed     Text format     Abstract available
     
     
     
115. GAITANIDIS A, Alevizakos M, Tsalikidis C, Tsaroucha A, et al
     Refusal of Cancer-Directed Surgery by Breast Cancer Patients: Risk Factors and Survival Outcomes.
     Clin Breast Cancer. 2017 Jul 18. pii: S1526-8209(17)30381.
     PubMed     Text format     Abstract available
     
     
     
116. OTSUBO R, Hirakawa H, Oikawa M, Baba M, et al
     Validation of a Novel Diagnostic Kit Using the Semidry Dot-Blot Method to Detect Metastatic Lymph Nodes in Breast Cancer: Distinguishing Macrometastases From Nonmacrometastases.
     Clin Breast Cancer. 2017 Jul 15. pii: S1526-8209(17)30274.
     PubMed     Text format     Abstract available
     
     
     
117. PARK AY, Seo BK, Han H, Cho KR, et al
     Clinical Value of Real-Time Ultrasonography-MRI Fusion Imaging for Second-Look Examination in Preoperative Breast Cancer Patients: Additional Lesion Detection and Treatment Planning.
     Clin Breast Cancer. 2017 Jul 14. pii: S1526-8209(17)30167.
     PubMed     Text format     Abstract available
     
     
     
118. CINAUSERO M, Gerratana L, De Carlo E, Iacono D, et al
     Determinants of Last-line Treatment in Metastatic Breast Cancer.
     Clin Breast Cancer. 2017 Jul 14. pii: S1526-8209(17)30270.
     PubMed     Text format     Abstract available
     
     
     
119. ALBESHAN SM, Mackey MG, Hossain SZ, Alfuraih AA, et al
     Breast Cancer Epidemiology in Gulf Cooperation Council Countries: A Regional and International Comparison.
     Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30108.
     PubMed     Text format     Abstract available
     
     
     
120. BATISTATOU A, Kotoula V, Bobos M, Kouvatseas G, et al
     Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.
     Clin Breast Cancer. 2017 Jul 13. pii: S1526-8209(17)30138.
     PubMed     Text format     Abstract available
     
     
     
121. DESNYDER SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, et al
     Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
     Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(17)30366.
     PubMed     Text format     Abstract available
     
     
     
122. GERSTL B, Sullivan E, Ives A, Saunders C, et al
     Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta-analysis.
     Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(16)30537.
     PubMed     Text format     Abstract available
     
     
     
123. OSBORNE C, Challagalla JD, Eisenbeis CF, Holmes FA, et al
     Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer.
     Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(16)30521.
     PubMed     Text format     Abstract available
     
     
     
124. MONTAGNA E, Pirola S, Maisonneuve P, De Roberto G, et al
     Lobular Metastatic Breast Cancer Patients With Gastrointestinal Involvement: Features and Outcomes.
     Clin Breast Cancer. 2017 Jul 10. pii: S1526-8209(17)30085.
     PubMed     Text format     Abstract available
     
     
     
125. FRATAMICO RS, Strickland KS, Uppal G, Abu-Khalaf M, et al
     A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia.
     Clin Breast Cancer. 2017 Jul 4. pii: S1526-8209(17)30092.
     PubMed     Text format    
     
     
     June 2017
126. YOKOYAMA S, Tamaru S, Tamaki S, Nakanishi D, et al
     Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy.
     Clin Breast Cancer. 2017 Jun 29. pii: S1526-8209(17)30142.
     PubMed     Text format     Abstract available
     
     
     
127. COLLARINO A, de Koster EJ, Valdes Olmos RA, de Geus-Oei LF, et al
     Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
     Clin Breast Cancer. 2017 Jun 29. pii: S1526-8209(17)30059.
     PubMed     Text format     Abstract available
     
     
     
128. STEGER GG, Dominguez A, Dobrovolskaya N, Giotta F, et al
     Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study.
     Clin Breast Cancer. 2017 Jun 27. pii: S1526-8209(16)30562.
     PubMed     Text format     Abstract available
     
     
     
129. IBRAHIM M, Muanza T, Smirnow N, Sateren W, et al
     A Pilot Randomized Controlled Trial on the Effects of a Progressive Exercise Program on the Range of Motion and Upper Extremity Grip Strength in Young Adults With Breast Cancer.
     Clin Breast Cancer. 2017 Jun 24. pii: S1526-8209(17)30032.
     PubMed     Text format     Abstract available
     
     
     
130. CHEN T, Zhang N, Moran MS, Su P, et al
     Borderline ER-Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta-Analysis.
     Clin Breast Cancer. 2017 Jun 23. pii: S1526-8209(16)30550.
     PubMed     Text format     Abstract available
     
     
     
131. PARK S, Lee JE, Yu J, Paik HJ, et al
     Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane.
     Clin Breast Cancer. 2017 Jun 21. pii: S1526-8209(16)30518.
     PubMed     Text format     Abstract available
     
     
     
132. CHOI SH, Kim JW, Choi J, Sohn J, et al
     Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
     Clin Breast Cancer. 2017 Jun 17. pii: S1526-8209(17)30306.
     PubMed     Text format     Abstract available
     
     
     
133. FU J, Wu L, Fu W, Tan Y, et al
     How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype.
     Clin Breast Cancer. 2017 Jun 8. pii: S1526-8209(17)30033.
     PubMed     Text format     Abstract available
     
     
     
134. SHAKER OG, Helmy HS
     Circulating Bone-related Markers and YKL-40 Versus HER2 and TOPO2a in Bone Metastatic and Nonmetastatic Breast Cancer: Diagnostic Implications.
     Clin Breast Cancer. 2017 Jun 7. pii: S1526-8209(17)30150.
     PubMed     Text format     Abstract available
     
     
     
135. ROBERT NJ, Denduluri N
     Patient Case Lessons: Endocrine Management of Advanced Breast Cancer.
     Clin Breast Cancer. 2017 Jun 7. pii: S1526-8209(16)30502.
     PubMed     Text format     Abstract available
     
     
     May 2017
136. YU E, Huang D, Leonard K, Dipetrillo T, et al
     Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
     Clin Breast Cancer. 2017 May 25. pii: S1526-8209(17)30115.
     PubMed     Text format     Abstract available
     
     
     
137. CHO YT, Su H, Chiang YY, Shiea J, et al
     Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
     Clin Breast Cancer. 2017 May 25. pii: S1526-8209(16)30538.
     PubMed     Text format     Abstract available
     
     
     
138. LOURENCO AP, Benson KL, Henderson MC, Silver M, et al
     A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
     Clin Breast Cancer. 2017 May 23. pii: S1526-8209(16)30412.
     PubMed     Text format     Abstract available
     
     
     
139. BASELGA J, Zamagni C, Gomez P, Bermejo B, et al
     RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
     Clin Breast Cancer. 2017 May 22. pii: S1526-8209(17)30005.
     PubMed     Text format     Abstract available
     
     
     
140. ADRASKELA K, Veisaki E, Koutsilieris M, Philippou A, et al
     Physical Exercise Positively Influences Breast Cancer Evolution.
     Clin Breast Cancer. 2017 May 19. pii: S1526-8209(16)30357.
     PubMed     Text format     Abstract available
     
     
     
141. BUONO G, Giuliano M, De Angelis C, Lauria R, et al
     Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.
     Clin Breast Cancer. 2017 May 19. pii: S1526-8209(17)30168.
     PubMed     Text format     Abstract available
     
     
     
142. BIGLIA N, Bounous VE, D'Alonzo M, Ottino L, et al
     Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists.
     Clin Breast Cancer. 2017 May 19. pii: S1526-8209(17)30095.
     PubMed     Text format     Abstract available
     
     
     
143. RAHBAR A, Touma J, Costa H, Davoudi B, et al
     Low Expression of Estrogen Receptor-alpha and Progesterone Receptor in Human Breast Cancer Tissues Is Associated With High-Grade Human Cytomegalovirus Protein Expression.
     Clin Breast Cancer. 2017 May 11. pii: S1526-8209(16)30411.
     PubMed     Text format     Abstract available
     
     
     
144. NOGI H, Uchida K, Mimoto R, Kamio M, et al
     Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
     Clin Breast Cancer. 2017 May 8. pii: S1526-8209(17)30221.
     PubMed     Text format     Abstract available
     
     
     
145. HUSSEIN MM, Gaafar RM, Abdel-Warith AM, Ahmed WA, et al
     Efficacy and Toxicity of Metronomic Chemotherapy in Metastatic Breast Cancer: Egyptian Experience.
     Clin Breast Cancer. 2017 May 8. pii: S1526-8209(17)30007.
     PubMed     Text format     Abstract available
     
     
     
146. DIANATINASAB M, Fararouei M, Mohammadianpanah M, Zare-Bandamiri M, et al
     Hair Coloring, Stress, and Smoking Increase the Risk of Breast Cancer: A Case-Control Study.
     Clin Breast Cancer. 2017 May 5. pii: S1526-8209(17)30135.
     PubMed     Text format     Abstract available
     
     
     April 2017
147. WERNER TL, Ray A, Lamb JG, VanBrocklin M, et al
     A Phase I Study of Neoadjuvant Chemotherapy With Nab-Paclitaxel, Doxorubicin, and Cyclophosphamide in Patients With Stage II to III Breast Cancer.
     Clin Breast Cancer. 2017 Apr 29. pii: S1526-8209(16)30425.
     PubMed     Text format     Abstract available
     
     
     
148. LI X, Yang J, Krishnamurti U, Huo L, et al
     Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
     Clin Breast Cancer. 2017 Apr 28. pii: S1526-8209(16)30531.
     PubMed     Text format     Abstract available
     
     
     
149. EL ZEIN D, Hughes M, Kumar S, Peng X, et al
     Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
     Clin Breast Cancer. 2017 Apr 26. pii: S1526-8209(16)30556.
     PubMed     Text format     Abstract available
     
     
     
150. MOHAMMADI A, Mansoori B, Baradaran PC, Khaze V, et al
     Urtica dioica Extract Inhibits Proliferation and Induces Apoptosis and Related Gene Expression of Breast Cancer Cells In Vitro and In Vivo.
     Clin Breast Cancer. 2017 Apr 21. pii: S1526-8209(16)30347.
     PubMed     Text format     Abstract available
     
     
     
151. AMORNSUPAK K, Jamjuntra P, Warnnissorn M, O-Charoenrat P, et al
     High ASMA+ Fibroblasts and Low Cytoplasmic HMGB1+ Breast Cancer Cells Predict Poor Prognosis.
     Clin Breast Cancer. 2017 Apr 21. pii: S1526-8209(16)30580.
     PubMed     Text format     Abstract available
     
     
     
152. VAN NIJNATTEN TJA, Simons JM, Smidt ML, van der Pol CC, et al
     A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch
     Clin Breast Cancer. 2017 Apr 19. pii: S1526-8209(17)30130.
     PubMed     Text format     Abstract available
     
     
     
153. HERMEL DJ, Wood ME, Chun J, Rounds T, et al
     Multi-institutional Evaluation of Women at High Risk of Developing Breast Cancer.
     Clin Breast Cancer. 2017 Apr 14. pii: S1526-8209(16)30264.
     PubMed     Text format     Abstract available
     
     
     
154. BELLIO G, Marion R, Giudici F, Kus S, et al
     Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis.
     Clin Breast Cancer. 2017 Apr 11. pii: S1526-8209(17)30174.
     PubMed     Text format     Abstract available
     
     
     
155. LAMBERTINI M, Ferreira AR, Di Meglio A, Poggio F, et al
     Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
     Clin Breast Cancer. 2017 Apr 11. pii: S1526-8209(17)30046.
     PubMed     Text format     Abstract available
     
     
     
156. MADUNIC J, Horvat L, Majstorovic I, Jodlowska I, et al
     Sodium Salicylate Inhibits Urokinase Activity in MDA MB-231 Breast Cancer Cells.
     Clin Breast Cancer. 2017 Apr 6. pii: S1526-8209(17)30106.
     PubMed     Text format     Abstract available
     
     
     March 2017
157. ZHANG X, Bleiweiss I, Jaffer S, Nayak A, et al
     The Impact of 2013 Updated ASCO/CAP HER2 Guidelines on the Diagnosis and Management of Invasive Breast Cancer: A Single-Center Study of 1739 Cases.
     Clin Breast Cancer. 2017 Mar 29. pii: S1526-8209(16)30360.
     PubMed     Text format     Abstract available
     
     
     
158. MENDEZ-HERNANDEZ A, Gallegos-Arreola MP, Moreno-Macias H, Espinosa Fematt J, et al
     LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 Polymorphisms Are Associated With Obesity and Chemotherapy Response in Mexican Women With Breast Cancer.
     Clin Breast Cancer. 2017 Mar 22. pii: S1526-8209(16)30246.
     PubMed     Text format     Abstract available
     
     
     
159. WADASADAWALA T, Vadgaonkar R, Bajpai J
     Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities.
     Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(16)30416.
     PubMed     Text format     Abstract available
     
     
     
160. GINTER PS, McIntire PJ, Cui X, Irshaid L, et al
     Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
     Clin Breast Cancer. 2017 Mar 21. pii: S1526-8209(17)30012.
     PubMed     Text format     Abstract available
     
     
     
161. VIDAL GA, Chen M, Sheth S, Svahn T, et al
     Phase I Trial of Everolimus and Capecitabine in Metastatic HER2- Breast Cancer.
     Clin Breast Cancer. 2017 Mar 16. pii: S1526-8209(16)30410.
     PubMed     Text format     Abstract available
     
     
     
162. BERNARDO A, Palumbo R, Pedersini R, Rota Caremoli E, et al
     Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.
     Clin Breast Cancer. 2017 Mar 9. pii: S1526-8209(16)30359.
     PubMed     Text format     Abstract available
     
     
     
163. CHAND AR, Ziauddin MF, Tang SC
     Can Locoregionally Recurrent Breast Cancer Be Cured?
     Clin Breast Cancer. 2017 Mar 2. pii: S1526-8209(17)30113.
     PubMed     Text format     Abstract available
     
     
     February 2017
164. ALTUNDAG K
     Flap Fixation Using Tissue Glue or Sutures After Mastectomy Might Also Reduce Risk of Developing Lymphedema in Breast Cancer.
     Clin Breast Cancer. 2017 Feb 20. pii: S1526-8209(17)30061.
     PubMed     Text format    
     
     
     
165. ALTUNDAG K
     Molecular Subtypes and Lower Inner Quadrant Tumors in Breast Cancer: Debate Is Still Ongoing.
     Clin Breast Cancer. 2017 Feb 17. pii: S1526-8209(17)30019.
     PubMed     Text format    
     
     
     
166. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
     Can MTHFR C677T and A1298C Polymorphisms Alter the Risk and Severity of Sporadic Breast Cancer in Brazilian Women?
     Clin Breast Cancer. 2017 Feb 16. pii: S1526-8209(16)30341.
     PubMed     Text format     Abstract available
     
     
     
167. WANG CH, Chang CJ, Yeh KY, Chang PH, et al
     The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
     Clin Breast Cancer. 2017 Feb 16. pii: S1526-8209(17)30086.
     PubMed     Text format     Abstract available
     
     
     January 2017
168. LEFEUVRE D, Le Bihan-Benjamin C, Pauporte I, Medioni J, et al
     French Medico-Administrative Data to Identify the Care Pathways of Women With Breast Cancer.
     Clin Breast Cancer. 2017 Jan 27. pii: S1526-8209(16)30321.
     PubMed     Text format     Abstract available
     
     
     
169. VAN BASTELAAR J, Theunissen LL, Snoeijs MG, Beets GL, et al
     Flap Fixation Using Tissue Glue or Sutures Appears to Reduce Seroma Aspiration After Mastectomy for Breast Cancer.
     Clin Breast Cancer. 2017 Jan 24. pii: S1526-8209(16)30565.
     PubMed     Text format     Abstract available
     
     
     
170. DE BOER MC, Worner EA, Verlaan D, van Leeuwen PA, et al
     The Mechanisms and Effects of Physical Activity on Breast Cancer.
     Clin Breast Cancer. 2017 Jan 24. pii: S1526-8209(16)30422.
     PubMed     Text format     Abstract available
     
     
     
171. CHAPMAN JW, Liu S, Leung S, Nielsen TO, et al
     Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.
     Clin Breast Cancer. 2017 Jan 20. pii: S1526-8209(16)30362.
     PubMed     Text format     Abstract available
     
     
     
172. LI G, Xu Z, Zhuang A, Chang S, et al
     Magnetic Resonance Spectroscopy-Detected Change in Marrow Adiposity Is Strongly Correlated to Postmenopausal Breast Cancer Risk.
     Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30011.
     PubMed     Text format     Abstract available
     
     
     
173. GHONCHEH M, Ziaee F, Karami M, Poorolajal J, et al
     Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
     Clin Breast Cancer. 2017 Jan 18. pii: S1526-8209(17)30010.
     PubMed     Text format     Abstract available
     
     
     
174. GU YL, Pan SM, Ren J, Yang ZX, et al
     Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis.
     Clin Breast Cancer. 2017 Jan 11. pii: S1526-8209(16)30256.
     PubMed     Text format     Abstract available
     
     
     
175. SCHRAMM A, Schochter F, Friedl TW, de Gregorio N, et al
     Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
     Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30257.
     PubMed     Text format     Abstract available
     
     
     
176. HWANG KT, Kim J, Kim EK, Jung SH, et al
     Poor Prognosis of Lower Inner Quadrant in Lymph Node-negative Breast Cancer Patients Who Received No Chemotherapy: A Study Based on Nationwide Korean Breast Cancer Registry Database.
     Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30269.
     PubMed     Text format     Abstract available
     
     
     
177. CONVERSANO A, Mazouni C, Thomin A, Gaudin A, et al
     Use of Low-Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma.
     Clin Breast Cancer. 2017 Jan 10. pii: S1526-8209(16)30449.
     PubMed     Text format     Abstract available
     
     
     
178. GOLSE N, Adam R
     Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results.
     Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30298.
     PubMed     Text format     Abstract available
     
     
     
179. NYE L, Rademaker A, Gradishar WJ
     Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
     Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30313.
     PubMed     Text format     Abstract available
     
     
     
180. MURPHY BL, Boughey JC, Hieken TJ
     Nipple-sparing Mastectomy for the Management of Recurrent Breast Cancer.
     Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30355.
     PubMed     Text format     Abstract available
     
     
     
181. ALTUNDAG K
     New Data About First-line All-oral Vinorelbine and Capecitabine in HER2-negative Metastatic Breast Cancer Confirms Results of Meta-analysis.
     Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30426.
     PubMed     Text format    
     
     
     
182. ALTUNDAG K
     Genomic Profiling of Brain Metastasis and Matched Primary Triple-negative Breast Cancer.
     Clin Breast Cancer. 2017 Jan 9. pii: S1526-8209(16)30409.
     PubMed     Text format    
     
     
     
183. SHEPPARD VB, Cavalli LR, Dash C, Kanaan YM, et al
     Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
     Clin Breast Cancer. 2017 Jan 6. pii: S1526-8209(16)30571.
     PubMed     Text format     Abstract available
     
     
     
184. DENU RA, Burkard ME
     Synchronous Bilateral Breast Cancer in a Patient With Nager Syndrome.
     Clin Breast Cancer. 2017 Jan 5. pii: S1526-8209(16)30577.
     PubMed     Text format    
     
     
     December 2016
185. JONES EF, Ray KM, Li W, Seo Y, et al
     Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
     Clin Breast Cancer. 2016 Dec 29. pii: S1526-8209(16)30576.
     PubMed     Text format    
     
     
     
186. YAN M, Wang J, Xuan Q, Dong T, et al
     The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
     Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30569.
     PubMed     Text format     Abstract available
     
     
     
187. AL-BAHLANI SM, Al-Bulushi KH, Al-Alawi ZM, Al-Abri NY, et al
     Cisplatin Induces Apoptosis Through the Endoplasmic Reticulum-mediated, Calpain 1 Pathway in Triple-negative Breast Cancer Cells.
     Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30566.
     PubMed     Text format     Abstract available
     
     
     
188. PEREIRA CB, Leal MF, Abdelhay ES, Demachki S, et al
     MYC Amplification as a Predictive Factor of Complete Pathologic Response to Docetaxel-based Neoadjuvant Chemotherapy for Breast Cancer.
     Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30570.
     PubMed     Text format     Abstract available
     
     
     
189. BENEDICT C, Thom B, Teplinsky E, Carleton J, et al
     Family-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine Therapy.
     Clin Breast Cancer. 2016 Dec 24. pii: S1526-8209(16)30567.
     PubMed     Text format     Abstract available
     
     
     November 2016
190. XIAO F, Song X, Chen Q, Dai Y, et al
     Effectiveness of Psychological Interventions on Depression in Patients After Breast Cancer Surgery: A Meta-analysis of Randomized Controlled Trials.
     Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30494.
     PubMed     Text format     Abstract available
     
     
     
191. GIATROMANOLAKI A, Sivridis E, Kalamida D, Koukourakis MI, et al
     Transcription Factor EB Expression in Early Breast Cancer Relates to Lysosomal/Autophagosomal Markers and Prognosis.
     Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30497.
     PubMed     Text format     Abstract available
     
     
     
192. TSENG CH
     Sitagliptin May Reduce Breast Cancer Risk in Women With Type 2 Diabetes.
     Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30493.
     PubMed     Text format     Abstract available
     
     
     
193. SATO K, Akimoto K
     Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in Estrogen Receptor-positive Breast Cancer.
     Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30496.
     PubMed     Text format     Abstract available
     
     
     
194. VILLARREAL-GARZA C, Mohar A, Bargallo-Rocha JE, Lasa-Gonsebatt F, et al
     Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer.
     Clin Breast Cancer. 2016 Nov 23. pii: S1526-8209(16)30498.
     PubMed     Text format     Abstract available
     
     
     
195. MUZAFFAR M, Kachare S, Vohra N
     Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer.
     Clin Breast Cancer. 2016 Nov 22. pii: S1526-8209(16)30492.
     PubMed     Text format     Abstract available
     
     
     October 2016
196. RYU JM, Park S, Paik HJ, Nam SJ, et al
     Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
     Clin Breast Cancer. 2016 Oct 27. pii: S1526-8209(16)30373.
     PubMed     Text format     Abstract available
     
     
     
197. KIM SH, Shin HJ, Shin KC, Chae EY, et al
     Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
     Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30374.
     PubMed     Text format     Abstract available
     
     
     
198. OJINNAKA CO, Luo W, Ory MG, McMaughan D, et al
     Disparities in Surgical Treatment of Early-Stage Breast Cancer Among Female Residents of Texas: The Role of Racial Residential Segregation.
     Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30370.
     PubMed     Text format     Abstract available
     
     
     
199. LEINERT E, Singer S, Janni W, Harbeck N, et al
     The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
     Clin Breast Cancer. 2016 Oct 19. pii: S1526-8209(16)30372.
     PubMed     Text format     Abstract available
     
     
     
200. MARRAZZO A, Damiano G, Taormina P, Buscemi S, et al
     Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
     Clin Breast Cancer. 2016 Oct 18. pii: S1526-8209(16)30365.
     PubMed     Text format     Abstract available
     
     
     September 2016
201. DUCHNOWSKA R, Jarzab M, Zebracka-Gala J, Matkowski R, et al
     Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.
     Clin Breast Cancer. 2016 Sep 8. pii: S1526-8209(16)30238.
     PubMed     Text format     Abstract available
     
     
     August 2016
202. GAO JJ, Tan M, Pohlmann PR, Swain SM, et al
     HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.
     Clin Breast Cancer. 2016 Aug 27. pii: S1526-8209(16)30235.
     PubMed     Text format     Abstract available
     
     
     
203. GLUCK S
     Consequences of the Convergence of Multiple Alternate Pathways on the Estrogen Receptor in the Treatment of Metastatic Breast Cancer.
     Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30234.
     PubMed     Text format     Abstract available
     
     
     
204. PIVO S, Montes J, Schwartz S, Chun J, et al
     Breast Cancer Risk Assessment and Screening in Transgender Patients.
     Clin Breast Cancer. 2016 Aug 25. pii: S1526-8209(16)30233.
     PubMed     Text format    
     
     
     
205. JASRA S, Opyrchal M, Norton L, Mehta R, et al
     A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.
     Clin Breast Cancer. 2016 Aug 18. pii: S1526-8209(16)30211.
     PubMed     Text format    
     
     
     
206. CADOO KA, Morris PG, Cowell EP, Patil S, et al
     Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
     Clin Breast Cancer. 2016 Aug 1. pii: S1526-8209(16)30206.
     PubMed     Text format     Abstract available
     
     
     July 2016
207. YARDLEY DA, Reeves J, Dees EC, Osborne C, et al
     Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
     Clin Breast Cancer. 2016 Jul 29. pii: S1526-8209(16)30198.
     PubMed     Text format     Abstract available
     
     
     
208. CHOI WJ, Cha JH, Kim HH, Shin HJ, et al
     The Accuracy of Breast MR Imaging for Measuring the Size of a Breast Cancer: Analysis of the Histopathologic Factors.
     Clin Breast Cancer. 2016 Jul 29. pii: S1526-8209(16)30200.
     PubMed     Text format     Abstract available
     
     
     
209. DUDANI S, Mazzarello S, Hilton J, Hutton B, et al
     Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.
     Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30207.
     PubMed     Text format     Abstract available
     
     
     
210. XUAN Q, Gao K, Song Y, Zhao S, et al
     Adherence to Needed Adjuvant Therapy Could Decrease Recurrence Rates for Rural Patients With Early Breast Cancer.
     Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30199.
     PubMed     Text format     Abstract available
     
     
     
211. ZHU W, Harvey S, Macura KJ, Euhus DM, et al
     Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.
     Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30202.
     PubMed     Text format     Abstract available
     
     
     
212. TECALCO-CRUZ AC, Ramirez-Jarquin JO
     Mechanisms that Increase Stability of Estrogen Receptor Alpha in Breast Cancer.
     Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30208.
     PubMed     Text format     Abstract available
     
     
     
213. WILKINSON JB, Shah C, Amin M, Nadeau L, et al
     Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation.
     Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30203.
     PubMed     Text format     Abstract available
     
     
     
214. SMITH JW 2ND, Buyse ME, Rastogi P, Geyer CE Jr, et al
     Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Tri
     Clin Breast Cancer. 2016 Jul 28. pii: S1526-8209(16)30201.
     PubMed     Text format     Abstract available
     
     
     
215. MORIKAWA A, Jordan L, Rozner R, Patil S, et al
     Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
     Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30177.
     PubMed     Text format     Abstract available
     
     
     
216. EDENFIELD J, Schammel C, Collins J, Schammel D, et al
     Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution.
     Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30197.
     PubMed     Text format     Abstract available
     
     
     
217. FOGLIETTA J, Inno A, de Iuliis F, Sini V, et al
     Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients.
     Clin Breast Cancer. 2016 Jul 25. pii: S1526-8209(16)30196.
     PubMed     Text format     Abstract available
     
     
     
218. HARRIS SR
     Differentiating the Causes of Spontaneous Rib Fracture After Breast Cancer.
     Clin Breast Cancer. 2016 Jul 15. pii: S1526-8209(16)30176.
     PubMed     Text format     Abstract available
     
     
     
219. PARK S, Lee JE, Paik HJ, Ryu JM, et al
     Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
     Clin Breast Cancer. 2016 Jul 9. pii: S1526-8209(16)30175.
     PubMed     Text format     Abstract available
     
     
     
220. TANAKA K, Tokunaga E, Inoue Y, Yamashita N, et al
     Impact of Expression of Vimentin and Axl in Breast Cancer.
     Clin Breast Cancer. 2016 Jul 5. pii: S1526-8209(16)30170.
     PubMed     Text format     Abstract available
     
     
     
221. S CHAPMAN J, Roddy E, Panighetti A, Hwang S, et al
     Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer.
     Clin Breast Cancer. 2016 Jul 5. pii: S1526-8209(16)30171.
     PubMed     Text format     Abstract available
     
     
     June 2016
222. LEE J, Jung JH, Kim WW, Hwang SO, et al
     Five-Year Oncologic Outcomes of Volume Displacement Procedures After Partial Mastectomy for Breast Cancer.
     Clin Breast Cancer. 2016 Jun 29. pii: S1526-8209(16)30173.
     PubMed     Text format     Abstract available
     
     
     
223. NAVARRO-RODRIGUEZ E, Diaz-Jimenez N, Ruiz-Rabelo J, Gomez-Luque I, et al
     Factors Associated With Disease Recurrence in Breast Cancer Patients With Negative Sentinel Lymph Node Biopsy.
     Clin Breast Cancer. 2016 Jun 27. pii: S1526-8209(16)30168.
     PubMed     Text format     Abstract available
     
     
     
224. VARILLA V, Taxel P, Tannenbaum S
     Metastatic Inflammatory Breast Cancer Associated With Multicentric Reticulohistiocytosis Successfully Treated With Zoledronic Acid.
     Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30166.
     PubMed     Text format    
     
     
     
225. DE IULIIS F, Salerno G, Corvino R, D'Aniello D, et al
     Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer.
     Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30165.
     PubMed     Text format     Abstract available
     
     
     
226. ONO M, Tsuda H, Yoshida M, Shimizu C, et al
     Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
     Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30167.
     PubMed     Text format     Abstract available
     
     
     
227. CINIERI S, Chan A, Altundag K, Vandebroek A, et al
     Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer.
     Clin Breast Cancer. 2016 Jun 25. pii: S1526-8209(16)30169.
     PubMed     Text format     Abstract available
     
     
     
228. DAUGHERTY EC, Daugherty MR, Bogart JA, Shapiro A, et al
     Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer.
     Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30172.
     PubMed     Text format     Abstract available
     
     
     
229. RAMAN R, Mott SL, Schroeder MC, Phadke S, et al
     Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
     Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30163.
     PubMed     Text format     Abstract available
     
     
     
230. BUFI E, Belli P, Di Matteo M, Giuliani M, et al
     Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer.
     Clin Breast Cancer. 2016 Jun 23. pii: S1526-8209(16)30162.
     PubMed     Text format     Abstract available
     
     
     
231. TAKAHASHI H, Kagara N, Tanei T, Naoi Y, et al
     Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
     Clin Breast Cancer. 2016 Jun 16. pii: S1526-8209(16)30148.
     PubMed     Text format     Abstract available
     
     
     
232. TZANNINIS IG, Kotteas EA, Ntanasis-Stathopoulos I, Kontogianni P, et al
     Management and Outcomes in Metaplastic Breast Cancer.
     Clin Breast Cancer. 2016 Jun 15. pii: S1526-8209(16)30144.
     PubMed     Text format     Abstract available
     
     
     
233. GIULIANI M, Patrolecco F, Rella R, Di Giovanni SE, et al
     Can Breast Cancer Biopsy Influence Sentinel Lymph Node Status?
     Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30147.
     PubMed     Text format     Abstract available
     
     
     
234. JEHN CF, Hemmati P, Lehenbauer-Dehm S, Kummel S, et al
     Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.
     Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30143.
     PubMed     Text format     Abstract available
     
     
     
235. ABRAMOVITZ M, Williams C, Loibl S, Leyland-Jones B, et al
     Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast Cancer.
     Clin Breast Cancer. 2016 Jun 14. pii: S1526-8209(16)30146.
     PubMed     Text format     Abstract available
     
     
     
236. AYTAC HO, Nursal TZ, Colakoglu T, Bolat FA, et al
     Seroma Cytology in Breast Cancer: An Underappreciated Issue.
     Clin Breast Cancer. 2016 Jun 8. pii: S1526-8209(16)30142.
     PubMed     Text format     Abstract available
     
     
     
237. CEBERIO N, Cuadra M, Mendizabal JL, Gorostiaga J, et al
     Should We Perform the Intraoperative Sentinel Lymph Node Biopsy in Breast Cancer?
     Clin Breast Cancer. 2016 Jun 8. pii: S1526-8209(16)30141.
     PubMed     Text format     Abstract available
     
     
     
238. TAKEI J, Tsunoda H, Yagata H, Suzuki K, et al
     Sustained Interruption of Anterior Interfaces Between Adipose Tissues and Mammary Glands in Ultrasonography After Complete Pathological Remission After Neoadjuvant Chemotherapy for Primary Breast Cancer.
     Clin Breast Cancer. 2016;16:196-201.
     PubMed     Text format     Abstract available
     
     
     May 2016
239. NEUHAUS V, Abdullayev N, Hellmich M, Kramer S, et al
     Association of Quality and Quantity of Bone Metastases and Computed Tomography Volumetric Bone Mineral Density With Prevalence of Vertebral Fractures in Breast Cancer Patients.
     Clin Breast Cancer. 2016 May 31. pii: S1526-8209(16)30106.
     PubMed     Text format     Abstract available
     
     
     
240. SHIINO S, Kinoshita T, Yoshida M, Jimbo K, et al
     Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.
     Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30110.
     PubMed     Text format     Abstract available
     
     
     
241. AZGHADI S, Daly M, Mayadev J
     Practice Patterns of Radiation Field Design for Sentinel Lymph Node-Positive Early-Stage Breast Cancer.
     Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30105.
     PubMed     Text format     Abstract available
     
     
     
242. NAKAUCHI C, Kagara N, Shimazu K, Shimomura A, et al
     Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
     Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30100.
     PubMed     Text format     Abstract available
     
     
     
243. YARDLEY DA, Ward PJ, Daniel BR, Eakle JF, et al
     Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial.
     Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30102.
     PubMed     Text format     Abstract available
     
     
     
244. GANZ PA, Hahn EE, Petersen L, Melisko ME, et al
     Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena).
     Clin Breast Cancer. 2016 May 14. pii: S1526-8209(16)30099.
     PubMed     Text format     Abstract available
     
     
     
245. TANG Y, Wang Y, Kiani MF, Wang B, et al
     Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.
     Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30108.
     PubMed     Text format     Abstract available
     
     
     
246. CHANG JS, Chen J, Weinberg VK, Fowble B, et al
     Evaluation of Heart Dose for Left-Sided Breast Cancer Patients Over an 11-Year Period Spanning the Transition From 2-Dimensional to 3-Dimensional Planning.
     Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30109.
     PubMed     Text format     Abstract available
     
     
     
247. ALGAN O, Zhao YD, Herman T
     Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer.
     Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30107.
     PubMed     Text format     Abstract available
     
     
     
248. PETRELLI F, Di Cosimo S, Lonati V, Barni S, et al
     Vinorelbine With Capecitabine, an Evergreen Doublet for Advanced Breast Cancer: A Systematic Literature Review and Pooled-Analysis of Phase II-III Studies.
     Clin Breast Cancer. 2016 May 13. pii: S1526-8209(16)30098.
     PubMed     Text format     Abstract available
     
     
     April 2016
249. HAMELINCK VC, Bastiaannet E, Pieterse AH, de Glas NA, et al
     A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer.
     Clin Breast Cancer. 2016 Apr 21. pii: S1526-8209(16)30083.
     PubMed     Text format     Abstract available
     
     
     March 2016
250. OHNO S
     Tolerability of Therapies Recommended for the Treatment of Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer.
     Clin Breast Cancer. 2016 Mar 12. pii: S1526-8209(16)30049.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: